chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Abdominal distension, Computerised tomogram normal, Constipation, Discomfort, Laboratory test normal
Clinical narrative: extream pain under sternum; This is a spontaneous report from a contactable consumer (patient). A 73-years-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number was not reported), dose 2 intramuscular on 15Feb2021 19:00 as dose 2, single for covid-19 immunisation. Medical history included hemorrhagic stroke from 16oct2018 and ongoing aphasia, transient ischemic attack from 08feb2021 to an unknown date CT scan, TEE, chest pain from 15Feb2021 and ongoing Chest pain not heart under sternum Hospitalized 25Feb2021. The patient previously took bnt162b2, dose 1, single, Intramuscular, right arm, for covid-19 immunization on 27Jan2021 14:00. Concomitant medications were not reported. Patient had not taken any treatment for reported events. The patient experienced extreme pain under sternum on 18Feb2021. The patient underwent laboratory tests and procedures which included CT (computerized tomogram) chest with contrast: all ok, on 10Mar2021, CT pelvis: all ok, on 25Feb2021 Blood work are ok, echocardiogram (TEE): unknown result on 08Feb2021, endoscopy: all ok on 03Mar2021, ultrasound abdomen: all ok on 26Feb2021, Ultrasound neck and chest: all ok on 10Mar2021, Upper GI: all ok on 25Feb2021. The outcome of the event was recovering.  Information about lot and batch number was requested.
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Swelling, Swelling face, X-ray with contrast upper gastrointestinal tract normal
Clinical narrative: extream pain under sternum; This is a spontaneous report from a contactable consumer (patient). A 73-years-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number was not reported), dose 2 intramuscular on 15Feb2021 19:00 as dose 2, single for covid-19 immunisation. Medical history included hemorrhagic stroke from 16oct2018 and ongoing aphasia, transient ischemic attack from 08feb2021 to an unknown date CT scan, TEE, chest pain from 15Feb2021 and ongoing Chest pain not heart under sternum Hospitalized 25Feb2021. The patient previously took bnt162b2, dose 1, single, Intramuscular, right arm, for covid-19 immunization on 27Jan2021 14:00. Concomitant medications were not reported. Patient had not taken any treatment for reported events. The patient experienced extreme pain under sternum on 18Feb2021. The patient underwent laboratory tests and procedures which included CT (computerized tomogram) chest with contrast: all ok, on 10Mar2021, CT pelvis: all ok, on 25Feb2021 Blood work are ok, echocardiogram (TEE): unknown result on 08Feb2021, endoscopy: all ok on 03Mar2021, ultrasound abdomen: all ok on 26Feb2021, Ultrasound neck and chest: all ok on 10Mar2021, Upper GI: all ok on 25Feb2021. The outcome of the event was recovering.  Information about lot and batch number was requested.
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Abdominal discomfort, Abdominal distension, Computerised tomogram, Endoscopy
Clinical narrative: extream pain under sternum; This is a spontaneous report from a contactable consumer (patient). A 73-years-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number was not reported), dose 2 intramuscular on 15Feb2021 19:00 as dose 2, single for covid-19 immunisation. Medical history included hemorrhagic stroke from 16oct2018 and ongoing aphasia, transient ischemic attack from 08feb2021 to an unknown date CT scan, TEE, chest pain from 15Feb2021 and ongoing Chest pain not heart under sternum Hospitalized 25Feb2021. The patient previously took bnt162b2, dose 1, single, Intramuscular, right arm, for covid-19 immunization on 27Jan2021 14:00. Concomitant medications were not reported. Patient had not taken any treatment for reported events. The patient experienced extreme pain under sternum on 18Feb2021. The patient underwent laboratory tests and procedures which included CT (computerized tomogram) chest with contrast: all ok, on 10Mar2021, CT pelvis: all ok, on 25Feb2021 Blood work are ok, echocardiogram (TEE): unknown result on 08Feb2021, endoscopy: all ok on 03Mar2021, ultrasound abdomen: all ok on 26Feb2021, Ultrasound neck and chest: all ok on 10Mar2021, Upper GI: all ok on 25Feb2021. The outcome of the event was recovering.  Information about lot and batch number was requested.
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Blood test normal, Chest pain, Computerised tomogram pelvis, Computerised tomogram thorax normal, Echocardiogram
Clinical narrative: extream pain under sternum; This is a spontaneous report from a contactable consumer (patient). A 73-years-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number was not reported), dose 2 intramuscular on 15Feb2021 19:00 as dose 2, single for covid-19 immunisation. Medical history included hemorrhagic stroke from 16oct2018 and ongoing aphasia, transient ischemic attack from 08feb2021 to an unknown date CT scan, TEE, chest pain from 15Feb2021 and ongoing Chest pain not heart under sternum Hospitalized 25Feb2021. The patient previously took bnt162b2, dose 1, single, Intramuscular, right arm, for covid-19 immunization on 27Jan2021 14:00. Concomitant medications were not reported. Patient had not taken any treatment for reported events. The patient experienced extreme pain under sternum on 18Feb2021. The patient underwent laboratory tests and procedures which included CT (computerized tomogram) chest with contrast: all ok, on 10Mar2021, CT pelvis: all ok, on 25Feb2021 Blood work are ok, echocardiogram (TEE): unknown result on 08Feb2021, endoscopy: all ok on 03Mar2021, ultrasound abdomen: all ok on 26Feb2021, Ultrasound neck and chest: all ok on 10Mar2021, Upper GI: all ok on 25Feb2021. The outcome of the event was recovering.  Information about lot and batch number was requested.
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Endoscopy normal, Endoscopy upper gastrointestinal tract normal, Scan with contrast normal, Ultrasound abdomen normal, Ultrasound chest
Clinical narrative: extream pain under sternum; This is a spontaneous report from a contactable consumer (patient). A 73-years-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number was not reported), dose 2 intramuscular on 15Feb2021 19:00 as dose 2, single for covid-19 immunisation. Medical history included hemorrhagic stroke from 16oct2018 and ongoing aphasia, transient ischemic attack from 08feb2021 to an unknown date CT scan, TEE, chest pain from 15Feb2021 and ongoing Chest pain not heart under sternum Hospitalized 25Feb2021. The patient previously took bnt162b2, dose 1, single, Intramuscular, right arm, for covid-19 immunization on 27Jan2021 14:00. Concomitant medications were not reported. Patient had not taken any treatment for reported events. The patient experienced extreme pain under sternum on 18Feb2021. The patient underwent laboratory tests and procedures which included CT (computerized tomogram) chest with contrast: all ok, on 10Mar2021, CT pelvis: all ok, on 25Feb2021 Blood work are ok, echocardiogram (TEE): unknown result on 08Feb2021, endoscopy: all ok on 03Mar2021, ultrasound abdomen: all ok on 26Feb2021, Ultrasound neck and chest: all ok on 10Mar2021, Upper GI: all ok on 25Feb2021. The outcome of the event was recovering.  Information about lot and batch number was requested.
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Ultrasound scan normal
Clinical narrative: extream pain under sternum; This is a spontaneous report from a contactable consumer (patient). A 73-years-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number was not reported), dose 2 intramuscular on 15Feb2021 19:00 as dose 2, single for covid-19 immunisation. Medical history included hemorrhagic stroke from 16oct2018 and ongoing aphasia, transient ischemic attack from 08feb2021 to an unknown date CT scan, TEE, chest pain from 15Feb2021 and ongoing Chest pain not heart under sternum Hospitalized 25Feb2021. The patient previously took bnt162b2, dose 1, single, Intramuscular, right arm, for covid-19 immunization on 27Jan2021 14:00. Concomitant medications were not reported. Patient had not taken any treatment for reported events. The patient experienced extreme pain under sternum on 18Feb2021. The patient underwent laboratory tests and procedures which included CT (computerized tomogram) chest with contrast: all ok, on 10Mar2021, CT pelvis: all ok, on 25Feb2021 Blood work are ok, echocardiogram (TEE): unknown result on 08Feb2021, endoscopy: all ok on 03Mar2021, ultrasound abdomen: all ok on 26Feb2021, Ultrasound neck and chest: all ok on 10Mar2021, Upper GI: all ok on 25Feb2021. The outcome of the event was recovering.  Information about lot and batch number was requested.
Age: 34.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Abdominal pain, Chest discomfort, Chills, Diarrhoea, Disturbance in attention
Clinical narrative: mild anaphylaxis, long term side effects too: brain fog, dropping things, hyper/hypoglycemia postprandial and nighttime, paresthesias, palpitations
Age: 34.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Dizziness, Dysphagia, Dyspnoea, Eye pruritus, Fatigue
Clinical narrative: mild anaphylaxis, long term side effects too: brain fog, dropping things, hyper/hypoglycemia postprandial and nighttime, paresthesias, palpitations
Age: 34.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Feeling abnormal, Headache, Influenza like illness, Nausea, Pain
Clinical narrative: mild anaphylaxis, long term side effects too: brain fog, dropping things, hyper/hypoglycemia postprandial and nighttime, paresthesias, palpitations
Age: 34.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Pharyngeal swelling, Pruritus, Pyrexia, Swollen tongue, Throat irritation
Clinical narrative: mild anaphylaxis, long term side effects too: brain fog, dropping things, hyper/hypoglycemia postprandial and nighttime, paresthesias, palpitations
Age: 34.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Visual impairment, Vomiting, Wheezing
Clinical narrative: mild anaphylaxis, long term side effects too: brain fog, dropping things, hyper/hypoglycemia postprandial and nighttime, paresthesias, palpitations
Age: 34.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Anaphylactic reaction, Feeling abnormal, Hyperglycaemia, Palpitations, Paraesthesia
Clinical narrative: mild anaphylaxis, long term side effects too: brain fog, dropping things, hyper/hypoglycemia postprandial and nighttime, paresthesias, palpitations
Age: 34.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Postprandial hypoglycaemia
Clinical narrative: mild anaphylaxis, long term side effects too: brain fog, dropping things, hyper/hypoglycemia postprandial and nighttime, paresthesias, palpitations
Age: 63.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Arthralgia, Chest pain, Chills, Lymphadenopathy, Neck pain
Clinical narrative: Injection site pain; Upper body muscle crumps/severe pain - most around neck area; Swollen lymph nodes; Headaches/ Any body movement causing head pain; neck pain/ Any body movement causing neck; Tiredness; Felling unwell; Dizziness; weakness; This is a spontaneous report from a contactable consumer, the patient. This report received from a 63-year-old male patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6200) via an unspecified route of administration in left arm on 11Mar2021 (at the age of 63-years-old) at 11:30 as a single dose for COVID-19 immunisation. The medical history reported that the patient had two ablations, otherwise regular exercise, active living style. The patient had not received any medications within two weeks of vaccine. The patient did not receive any other vaccines within 4 weeks prior to the COVID-19 vaccine. Prior to vaccination the patient was not diagnosed with COVID-19. The patient had not been tested positive for COVID-19 since having the vaccine. On 13Mar2021, the patient experienced vaccination site pain, upper body muscle crumps mostly around neck area, swollen lymph nodes, severe constant headaches with neck pain, tiredness, felling unwell, dizziness and weakness and any body movement causing neck to head pain. The event resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as results of events and included the treatment with naproxen 500mg, baclofen 10mg. The clinical outcome of the events vaccination site pain, upper body muscle crumps mostly around neck area, swollen lymph nodes, severe constant headaches with neck pain, tiredness, felling unwell, dizziness and weakness and any body movement causing neck to head pain were not resolved at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 63.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Pain in extremity
Clinical narrative: Injection site pain; Upper body muscle crumps/severe pain - most around neck area; Swollen lymph nodes; Headaches/ Any body movement causing head pain; neck pain/ Any body movement causing neck; Tiredness; Felling unwell; Dizziness; weakness; This is a spontaneous report from a contactable consumer, the patient. This report received from a 63-year-old male patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6200) via an unspecified route of administration in left arm on 11Mar2021 (at the age of 63-years-old) at 11:30 as a single dose for COVID-19 immunisation. The medical history reported that the patient had two ablations, otherwise regular exercise, active living style. The patient had not received any medications within two weeks of vaccine. The patient did not receive any other vaccines within 4 weeks prior to the COVID-19 vaccine. Prior to vaccination the patient was not diagnosed with COVID-19. The patient had not been tested positive for COVID-19 since having the vaccine. On 13Mar2021, the patient experienced vaccination site pain, upper body muscle crumps mostly around neck area, swollen lymph nodes, severe constant headaches with neck pain, tiredness, felling unwell, dizziness and weakness and any body movement causing neck to head pain. The event resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as results of events and included the treatment with naproxen 500mg, baclofen 10mg. The clinical outcome of the events vaccination site pain, upper body muscle crumps mostly around neck area, swollen lymph nodes, severe constant headaches with neck pain, tiredness, felling unwell, dizziness and weakness and any body movement causing neck to head pain were not resolved at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 63.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Asthenia, Dizziness, Fatigue, Headache, Lymphadenopathy
Clinical narrative: Injection site pain; Upper body muscle crumps/severe pain - most around neck area; Swollen lymph nodes; Headaches/ Any body movement causing head pain; neck pain/ Any body movement causing neck; Tiredness; Felling unwell; Dizziness; weakness; This is a spontaneous report from a contactable consumer, the patient. This report received from a 63-year-old male patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6200) via an unspecified route of administration in left arm on 11Mar2021 (at the age of 63-years-old) at 11:30 as a single dose for COVID-19 immunisation. The medical history reported that the patient had two ablations, otherwise regular exercise, active living style. The patient had not received any medications within two weeks of vaccine. The patient did not receive any other vaccines within 4 weeks prior to the COVID-19 vaccine. Prior to vaccination the patient was not diagnosed with COVID-19. The patient had not been tested positive for COVID-19 since having the vaccine. On 13Mar2021, the patient experienced vaccination site pain, upper body muscle crumps mostly around neck area, swollen lymph nodes, severe constant headaches with neck pain, tiredness, felling unwell, dizziness and weakness and any body movement causing neck to head pain. The event resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as results of events and included the treatment with naproxen 500mg, baclofen 10mg. The clinical outcome of the events vaccination site pain, upper body muscle crumps mostly around neck area, swollen lymph nodes, severe constant headaches with neck pain, tiredness, felling unwell, dizziness and weakness and any body movement causing neck to head pain were not resolved at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 63.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Malaise, Muscle spasms, Neck pain, Vaccination site pain
Clinical narrative: Injection site pain; Upper body muscle crumps/severe pain - most around neck area; Swollen lymph nodes; Headaches/ Any body movement causing head pain; neck pain/ Any body movement causing neck; Tiredness; Felling unwell; Dizziness; weakness; This is a spontaneous report from a contactable consumer, the patient. This report received from a 63-year-old male patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6200) via an unspecified route of administration in left arm on 11Mar2021 (at the age of 63-years-old) at 11:30 as a single dose for COVID-19 immunisation. The medical history reported that the patient had two ablations, otherwise regular exercise, active living style. The patient had not received any medications within two weeks of vaccine. The patient did not receive any other vaccines within 4 weeks prior to the COVID-19 vaccine. Prior to vaccination the patient was not diagnosed with COVID-19. The patient had not been tested positive for COVID-19 since having the vaccine. On 13Mar2021, the patient experienced vaccination site pain, upper body muscle crumps mostly around neck area, swollen lymph nodes, severe constant headaches with neck pain, tiredness, felling unwell, dizziness and weakness and any body movement causing neck to head pain. The event resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as results of events and included the treatment with naproxen 500mg, baclofen 10mg. The clinical outcome of the events vaccination site pain, upper body muscle crumps mostly around neck area, swollen lymph nodes, severe constant headaches with neck pain, tiredness, felling unwell, dizziness and weakness and any body movement causing neck to head pain were not resolved at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 27.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Dizziness, Feeling abnormal, Nausea
Clinical narrative: Light-headed; Skin pink; Dry skin; Skin warm; Nausea; Heartbeat everywhere; This is a spontaneous report from a non-contactable healthcare professional for patient. A 27-year-old female patient of unknown pregnancy received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6204), via intramuscular route of administration on 06Mar2021 at 14:00 (at the age of 27-year-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were denied. The patient previously received morphine (MANUFACTURER UNKNOWN) and amoxicillin (MANUFACTURER UNKNOWN) for unspecified indication and experienced drug allergy (unknown reaction). Prior to vaccination, it was unknown if the patient had symptoms associated with COVID-19. Since vaccination, it was unknown if the patient was tested COVID-19 positive. It was unknown if the patient received any other vaccines within 4 weeks. On 06Mar2021 at 14:05 (approximately 5 minutes post vaccination), the patient experienced light headedness and nausea. The patient was able to feel the heartbeat everywhere (palpitation). The patient was alert and oriented and was further noted with skin pink, warm and dry. The patient was placed on gurney and assessed by emergency medical services and physician on duty and was continued observation in first aid area. The patient was given water and was reported that symptoms were improving. The patient was cleared for to discharge home by physician on duty. The patient did not receive treatment for the reported events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events dry skin, light-headed, nausea, skin pink, skin warm and palpitation was recovered on 06Mar2021 at 14:41 (able to sit upright without symptoms).   No follow-up attempts are needed. No further information is expected.
Age: 27.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Dizziness, Dry skin, Nausea, Pallor, Palpitations
Clinical narrative: Light-headed; Skin pink; Dry skin; Skin warm; Nausea; Heartbeat everywhere; This is a spontaneous report from a non-contactable healthcare professional for patient. A 27-year-old female patient of unknown pregnancy received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6204), via intramuscular route of administration on 06Mar2021 at 14:00 (at the age of 27-year-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were denied. The patient previously received morphine (MANUFACTURER UNKNOWN) and amoxicillin (MANUFACTURER UNKNOWN) for unspecified indication and experienced drug allergy (unknown reaction). Prior to vaccination, it was unknown if the patient had symptoms associated with COVID-19. Since vaccination, it was unknown if the patient was tested COVID-19 positive. It was unknown if the patient received any other vaccines within 4 weeks. On 06Mar2021 at 14:05 (approximately 5 minutes post vaccination), the patient experienced light headedness and nausea. The patient was able to feel the heartbeat everywhere (palpitation). The patient was alert and oriented and was further noted with skin pink, warm and dry. The patient was placed on gurney and assessed by emergency medical services and physician on duty and was continued observation in first aid area. The patient was given water and was reported that symptoms were improving. The patient was cleared for to discharge home by physician on duty. The patient did not receive treatment for the reported events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events dry skin, light-headed, nausea, skin pink, skin warm and palpitation was recovered on 06Mar2021 at 14:41 (able to sit upright without symptoms).   No follow-up attempts are needed. No further information is expected.
Age: 27.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Skin warm
Clinical narrative: Light-headed; Skin pink; Dry skin; Skin warm; Nausea; Heartbeat everywhere; This is a spontaneous report from a non-contactable healthcare professional for patient. A 27-year-old female patient of unknown pregnancy received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6204), via intramuscular route of administration on 06Mar2021 at 14:00 (at the age of 27-year-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were denied. The patient previously received morphine (MANUFACTURER UNKNOWN) and amoxicillin (MANUFACTURER UNKNOWN) for unspecified indication and experienced drug allergy (unknown reaction). Prior to vaccination, it was unknown if the patient had symptoms associated with COVID-19. Since vaccination, it was unknown if the patient was tested COVID-19 positive. It was unknown if the patient received any other vaccines within 4 weeks. On 06Mar2021 at 14:05 (approximately 5 minutes post vaccination), the patient experienced light headedness and nausea. The patient was able to feel the heartbeat everywhere (palpitation). The patient was alert and oriented and was further noted with skin pink, warm and dry. The patient was placed on gurney and assessed by emergency medical services and physician on duty and was continued observation in first aid area. The patient was given water and was reported that symptoms were improving. The patient was cleared for to discharge home by physician on duty. The patient did not receive treatment for the reported events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events dry skin, light-headed, nausea, skin pink, skin warm and palpitation was recovered on 06Mar2021 at 14:41 (able to sit upright without symptoms).   No follow-up attempts are needed. No further information is expected.
Age: 57.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Dyspnoea
Clinical narrative: SOB; This is a spontaneous report from a contactable other healthcare professional. A 57-year-old female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6204), via intramuscular on 06Mar2021 at 14:30 (at the age of 57-years-old) as a single dose for COVID-19 immunisation. Medical history included asthma. Concomitant medications included albuterol inhaler (MANUFACTURER UNKNOWN) for asthma which was received within two weeks of vaccine. It was unknown whether the patient was pregnant at the time of vaccination. It was unknown whether the patient received any other vaccines within 4 weeks prior to the COVID vaccine. It was unknown whether the patient was diagnosed with COVID-19 prior to the vaccination. It was unknown whether the patient had been tested for COVID-19, since the vaccination. On 06Mar2021 at 14:50 (reported as twenty minutes after the vaccine), the patient had experienced SOB (shortness of breath). The patient took two puffs of Albuterol inhaler for asthma and she felt immediate relief. The patient did not have SOB, cough and chest tightness. Her oxygen saturation was 99% on RA. After 45 minutes of observation, it was returned to baseline. The patient did not receive any treatment for the reported events. Adverse events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the event SOB was resolved on 06Mar2021.   No follow-up attempts are needed. No further information is expected.
Age: 57.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Dyspnoea, Oxygen saturation
Clinical narrative: SOB; This is a spontaneous report from a contactable other healthcare professional. A 57-year-old female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6204), via intramuscular on 06Mar2021 at 14:30 (at the age of 57-years-old) as a single dose for COVID-19 immunisation. Medical history included asthma. Concomitant medications included albuterol inhaler (MANUFACTURER UNKNOWN) for asthma which was received within two weeks of vaccine. It was unknown whether the patient was pregnant at the time of vaccination. It was unknown whether the patient received any other vaccines within 4 weeks prior to the COVID vaccine. It was unknown whether the patient was diagnosed with COVID-19 prior to the vaccination. It was unknown whether the patient had been tested for COVID-19, since the vaccination. On 06Mar2021 at 14:50 (reported as twenty minutes after the vaccine), the patient had experienced SOB (shortness of breath). The patient took two puffs of Albuterol inhaler for asthma and she felt immediate relief. The patient did not have SOB, cough and chest tightness. Her oxygen saturation was 99% on RA. After 45 minutes of observation, it was returned to baseline. The patient did not receive any treatment for the reported events. Adverse events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the event SOB was resolved on 06Mar2021.   No follow-up attempts are needed. No further information is expected.
Age: 60.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Arthralgia, Headache, Hypoaesthesia, Paraesthesia
Clinical narrative: Numb tingly fingers is the worst; Tingly fingers; Upper body joint ache in neck, shoulder, elbow, wrist, hands; Infrequent headache; This is a spontaneous report from a contactable consumer, the patient. A 60-year-old male patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6204) via unspecified route of administration in the left arm, on 19Mar2021 at 15:30 (at the age of 60-years-old) for COVID-19 immunisation. Medical history includes Barretts esophagus and crab allergy (seafood allergy). The patient did not receive any other medications within two weeks of vaccination. The patient did not receive any other vaccines within 4 weeks prior to the COVID-19 vaccine. Prior to vaccination, the patient had not been diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 19Mar2021 at 17:00 patient experienced numb tingly fingers, upper body joints ache, neck, shoulders, elbows, wrists & hands, infrequent headaches. The patient described numb tingly fingers as worst. Therapeutic measures and treatment were not received as a result of reported events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of numbness in fingers and tingling (in fingers), joints ache and headache were not resolved.   No follow-up attempts are needed. No further information is expected.
Age: 35.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Arthralgia, Chest pain, Cough, Dizziness, Fatigue
Clinical narrative: Injection site pain; Fever; Joint pain; Tiredness; Cough; Chest pain in the morning when woke up; Dizziness when turning a head; Severe headache on the right side of the back of the head and some in the forehead (Open a mouth to eat worsen thebackhead headache); This is a spontaneous report received from a contactable other healthcare professional, the patient. A 35-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: EN6203), via an unspecified route of administration in the right arm on 11Mar2021 at 07:15 (at the age of 35-years-old), as a single dose for COVID-19 immunisation. The patient had no medical history. Concomitant medications included ibuprofen (MANUFACTURER UNKNOWN), acetaminophen (MANUFACTURER UNKNOWN) and aspirin (MANUFACTURER UNKNOWN); all for unknown indications from unknown date. The patient did not have any allergies to food, medications, or other products. The patient did not receive any other vaccines within 4 weeks prior to the COVID-19 vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 12Mar2021 at 07:15, the patient experienced injection site pain, fever, joint pain, cough, tiredness. On an unspecified date in Mar2021 (2-4 days after vaccination), the patient experienced chest pain in the morning when woke up. On an unspecified date in Mar2021 (2-12 days after vaccination), the patient experienced dizziness when turning a head and severe headache on the right side of the back of the head and some in the forehead (Open a mouth to eat worsen the back head headache). The symptoms remained throughout the day both while sleeping and when working. The patient also reported that his second dose was scheduled on 01Apr2021, but he was afraid to do it especially if his symptoms remain same. The patient was working part time at the time of this report and had no insurance coverage to see a doctor. The events did not result in doctor or other health care professional office/clinic visit, and emergency room/department or urgent care. It was unknown whether patient receive any treatment for events or not. The clinical outcome of the injection site pain, fever, joint pain, cough, tiredness, chest pain, dizziness and headache were not resolved at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 35.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Headache, Injection site pain, Pyrexia
Clinical narrative: Injection site pain; Fever; Joint pain; Tiredness; Cough; Chest pain in the morning when woke up; Dizziness when turning a head; Severe headache on the right side of the back of the head and some in the forehead (Open a mouth to eat worsen thebackhead headache); This is a spontaneous report received from a contactable other healthcare professional, the patient. A 35-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: EN6203), via an unspecified route of administration in the right arm on 11Mar2021 at 07:15 (at the age of 35-years-old), as a single dose for COVID-19 immunisation. The patient had no medical history. Concomitant medications included ibuprofen (MANUFACTURER UNKNOWN), acetaminophen (MANUFACTURER UNKNOWN) and aspirin (MANUFACTURER UNKNOWN); all for unknown indications from unknown date. The patient did not have any allergies to food, medications, or other products. The patient did not receive any other vaccines within 4 weeks prior to the COVID-19 vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 12Mar2021 at 07:15, the patient experienced injection site pain, fever, joint pain, cough, tiredness. On an unspecified date in Mar2021 (2-4 days after vaccination), the patient experienced chest pain in the morning when woke up. On an unspecified date in Mar2021 (2-12 days after vaccination), the patient experienced dizziness when turning a head and severe headache on the right side of the back of the head and some in the forehead (Open a mouth to eat worsen the back head headache). The symptoms remained throughout the day both while sleeping and when working. The patient also reported that his second dose was scheduled on 01Apr2021, but he was afraid to do it especially if his symptoms remain same. The patient was working part time at the time of this report and had no insurance coverage to see a doctor. The events did not result in doctor or other health care professional office/clinic visit, and emergency room/department or urgent care. It was unknown whether patient receive any treatment for events or not. The clinical outcome of the injection site pain, fever, joint pain, cough, tiredness, chest pain, dizziness and headache were not resolved at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 35.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Headache, Pyrexia, Vaccination site pain
Clinical narrative: Injection site pain; Fever; Joint pain; Tiredness; Cough; Chest pain in the morning when woke up; Dizziness when turning a head; Severe headache on the right side of the back of the head and some in the forehead (Open a mouth to eat worsen thebackhead headache); This is a spontaneous report received from a contactable other healthcare professional, the patient. A 35-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: EN6203), via an unspecified route of administration in the right arm on 11Mar2021 at 07:15 (at the age of 35-years-old), as a single dose for COVID-19 immunisation. The patient had no medical history. Concomitant medications included ibuprofen (MANUFACTURER UNKNOWN), acetaminophen (MANUFACTURER UNKNOWN) and aspirin (MANUFACTURER UNKNOWN); all for unknown indications from unknown date. The patient did not have any allergies to food, medications, or other products. The patient did not receive any other vaccines within 4 weeks prior to the COVID-19 vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 12Mar2021 at 07:15, the patient experienced injection site pain, fever, joint pain, cough, tiredness. On an unspecified date in Mar2021 (2-4 days after vaccination), the patient experienced chest pain in the morning when woke up. On an unspecified date in Mar2021 (2-12 days after vaccination), the patient experienced dizziness when turning a head and severe headache on the right side of the back of the head and some in the forehead (Open a mouth to eat worsen the back head headache). The symptoms remained throughout the day both while sleeping and when working. The patient also reported that his second dose was scheduled on 01Apr2021, but he was afraid to do it especially if his symptoms remain same. The patient was working part time at the time of this report and had no insurance coverage to see a doctor. The events did not result in doctor or other health care professional office/clinic visit, and emergency room/department or urgent care. It was unknown whether patient receive any treatment for events or not. The clinical outcome of the injection site pain, fever, joint pain, cough, tiredness, chest pain, dizziness and headache were not resolved at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 31.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Computerised tomogram normal, Electric shock sensation, Eye pruritus, Facial paralysis, Lacrimation increased
Clinical narrative: Severe, constant neuropathy in face, scalp, legs, and feet for 4 months since receiving the vaccine.; Severe, constant paraesthesias in face, scalp, legs, and feet for 4 months since receiving the vaccine.; swollen joints; Have not had more than an hour without experiencing the absurd pain and  grotesque sensations; Transient muscle spasms; internal vibrations; chest pain; swollen lymph nodes; This is a spontaneous report from a contactable consumer (patient). A 31-years-old non-pregnant female patient received first dose of bnt162b2 (BNT162B2, Formulation: Solution for injection, Lot number and Expiration date: unknown), via an unknown route of administration, in left arm on 23Feb2021 at 13:30 (at the age of 31-years-old) as dose 1, single for covid-19 immunisation. The patient medical history was not reported. Concomitant medications included albuterol [salbutamol] (ALBUTEROL [SALBUTAMOL]) and formoterol fumarate (SYMBICORT) taken for an unspecified indication, start and stop date were not reported. Patient did not receive any other vaccine within 4 weeks prior to the covid vaccine. Prior to vaccination, the patient was not diagnosed with covid-19 and not tested for covid-19 since the vaccination. On 04Mar2021, the patient experienced severe, constant neuropathy in face, scalp, legs, and feet for 4 months since receiving the vaccine. Have not had more than an hour without experiencing the absurd pain and grotesque sensations. Transient muscle spasms, swollen lymph nodes, internal vibrations, chest pain and swollen joints. She has now spent thousands of dollars on tests, doctor appointments and medications. It would be thousands more before she was healed. She was disabled and have lost half of my income. She was healthy and active now her blood work was positive for the same immune-mediated reactions one gets after a severe virus. It was reported that these vaccines were not safe and effective. They were generally safe but not without their risks. They should be marketed with transparency. Every day she hear of more people suffering from this and the reaction was becoming increasingly known. Do something about it.The events were assessed as serious (disability). The events resulted in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. No treatment was received for events. Outcome of events was not recovered.
Age: 31.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Neuropathy peripheral, Paraesthesia
Clinical narrative: Severe, constant neuropathy in face, scalp, legs, and feet for 4 months since receiving the vaccine.; Severe, constant paraesthesias in face, scalp, legs, and feet for 4 months since receiving the vaccine.; swollen joints; Have not had more than an hour without experiencing the absurd pain and  grotesque sensations; Transient muscle spasms; internal vibrations; chest pain; swollen lymph nodes; This is a spontaneous report from a contactable consumer (patient). A 31-years-old non-pregnant female patient received first dose of bnt162b2 (BNT162B2, Formulation: Solution for injection, Lot number and Expiration date: unknown), via an unknown route of administration, in left arm on 23Feb2021 at 13:30 (at the age of 31-years-old) as dose 1, single for covid-19 immunisation. The patient medical history was not reported. Concomitant medications included albuterol [salbutamol] (ALBUTEROL [SALBUTAMOL]) and formoterol fumarate (SYMBICORT) taken for an unspecified indication, start and stop date were not reported. Patient did not receive any other vaccine within 4 weeks prior to the covid vaccine. Prior to vaccination, the patient was not diagnosed with covid-19 and not tested for covid-19 since the vaccination. On 04Mar2021, the patient experienced severe, constant neuropathy in face, scalp, legs, and feet for 4 months since receiving the vaccine. Have not had more than an hour without experiencing the absurd pain and grotesque sensations. Transient muscle spasms, swollen lymph nodes, internal vibrations, chest pain and swollen joints. She has now spent thousands of dollars on tests, doctor appointments and medications. It would be thousands more before she was healed. She was disabled and have lost half of my income. She was healthy and active now her blood work was positive for the same immune-mediated reactions one gets after a severe virus. It was reported that these vaccines were not safe and effective. They were generally safe but not without their risks. They should be marketed with transparency. Every day she hear of more people suffering from this and the reaction was becoming increasingly known. Do something about it.The events were assessed as serious (disability). The events resulted in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. No treatment was received for events. Outcome of events was not recovered.
Age: 31.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Blood test, Chest pain, Joint swelling, Lymphadenopathy, Muscle spasms
Clinical narrative: Severe, constant neuropathy in face, scalp, legs, and feet for 4 months since receiving the vaccine.; Severe, constant paraesthesias in face, scalp, legs, and feet for 4 months since receiving the vaccine.; swollen joints; Have not had more than an hour without experiencing the absurd pain and  grotesque sensations; Transient muscle spasms; internal vibrations; chest pain; swollen lymph nodes; This is a spontaneous report from a contactable consumer (patient). A 31-years-old non-pregnant female patient received first dose of bnt162b2 (BNT162B2, Formulation: Solution for injection, Lot number and Expiration date: unknown), via an unknown route of administration, in left arm on 23Feb2021 at 13:30 (at the age of 31-years-old) as dose 1, single for covid-19 immunisation. The patient medical history was not reported. Concomitant medications included albuterol [salbutamol] (ALBUTEROL [SALBUTAMOL]) and formoterol fumarate (SYMBICORT) taken for an unspecified indication, start and stop date were not reported. Patient did not receive any other vaccine within 4 weeks prior to the covid vaccine. Prior to vaccination, the patient was not diagnosed with covid-19 and not tested for covid-19 since the vaccination. On 04Mar2021, the patient experienced severe, constant neuropathy in face, scalp, legs, and feet for 4 months since receiving the vaccine. Have not had more than an hour without experiencing the absurd pain and grotesque sensations. Transient muscle spasms, swollen lymph nodes, internal vibrations, chest pain and swollen joints. She has now spent thousands of dollars on tests, doctor appointments and medications. It would be thousands more before she was healed. She was disabled and have lost half of my income. She was healthy and active now her blood work was positive for the same immune-mediated reactions one gets after a severe virus. It was reported that these vaccines were not safe and effective. They were generally safe but not without their risks. They should be marketed with transparency. Every day she hear of more people suffering from this and the reaction was becoming increasingly known. Do something about it.The events were assessed as serious (disability). The events resulted in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. No treatment was received for events. Outcome of events was not recovered.
Age: 31.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Neuropathy peripheral, Pain, Paraesthesia, Tremor
Clinical narrative: Severe, constant neuropathy in face, scalp, legs, and feet for 4 months since receiving the vaccine.; Severe, constant paraesthesias in face, scalp, legs, and feet for 4 months since receiving the vaccine.; swollen joints; Have not had more than an hour without experiencing the absurd pain and  grotesque sensations; Transient muscle spasms; internal vibrations; chest pain; swollen lymph nodes; This is a spontaneous report from a contactable consumer (patient). A 31-years-old non-pregnant female patient received first dose of bnt162b2 (BNT162B2, Formulation: Solution for injection, Lot number and Expiration date: unknown), via an unknown route of administration, in left arm on 23Feb2021 at 13:30 (at the age of 31-years-old) as dose 1, single for covid-19 immunisation. The patient medical history was not reported. Concomitant medications included albuterol [salbutamol] (ALBUTEROL [SALBUTAMOL]) and formoterol fumarate (SYMBICORT) taken for an unspecified indication, start and stop date were not reported. Patient did not receive any other vaccine within 4 weeks prior to the covid vaccine. Prior to vaccination, the patient was not diagnosed with covid-19 and not tested for covid-19 since the vaccination. On 04Mar2021, the patient experienced severe, constant neuropathy in face, scalp, legs, and feet for 4 months since receiving the vaccine. Have not had more than an hour without experiencing the absurd pain and grotesque sensations. Transient muscle spasms, swollen lymph nodes, internal vibrations, chest pain and swollen joints. She has now spent thousands of dollars on tests, doctor appointments and medications. It would be thousands more before she was healed. She was disabled and have lost half of my income. She was healthy and active now her blood work was positive for the same immune-mediated reactions one gets after a severe virus. It was reported that these vaccines were not safe and effective. They were generally safe but not without their risks. They should be marketed with transparency. Every day she hear of more people suffering from this and the reaction was becoming increasingly known. Do something about it.The events were assessed as serious (disability). The events resulted in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. No treatment was received for events. Outcome of events was not recovered.